Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) fell on Friday after the companies agreed to offer their blockbuster weight-loss drugs at sharply discounted prices in the U.S. as part of a major drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback